Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002254.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -7.92 1.35 1.47
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 481.52 20.89 -3.59
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 4.52 8.60 8.23
Cash -8.81 2.85 3.12
Capex -51.05 -0.74 -0.49
Free Cash Flow -173.49 -1.03 -0.38
Revenue -0.12 1.15 1.15
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -21.24 0.18 0.22
Operating Margin -67.67 0.02 0.07
ROA -56.47 < 0.005 < 0.005
ROE -53.67 < 0.005 < 0.005
ROIC -69.79 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002254.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002254.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002254.SZ is permitted for members.